Sven-Ulrik Gorr

9PUBLICATIONS
2CO-AUTHORS
Medical devicesProteins and peptidesMedical infection agents (incl. prions)PeriodonticsDental materials and equipment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 28, 2026
Correction: Gorr, S.-U. Targeted Modification of the Antimicrobial Peptide DGL13K Reveals a Naturally Optimized Sequence for Topical Applications. Microorganisms 2025, 13, 2355.

Sven-Ulrik Gorr

|Oct 29, 2025
Targeted Modification of the Antimicrobial Peptide DGL13K Reveals a Naturally Optimized Sequence for Topical Applications.

Sven-Ulrik Gorr

|Jun 04, 2025
Resisting the resistance: the antimicrobial peptide DGL13K selects for small colony variants of Staphylococcus aureus that show increased resistance to its stereoisomer LGL13K, but not to DGL13K.

Sven-Ulrik Gorr

|Oct 24, 2024
The oral pathogen Porphyromonas gingivalis gains tolerance to the antimicrobial peptide DGL13K by synonymous mutations in hagA.

Sven-Ulrik Gorr, Ruoqiong Chen, Juan E Abrahante

|Aug 25, 2022
The antimicrobial peptide DGL13K is active against drug-resistant gram-negative bacteria and sub-inhibitory concentrations stimulate bacterial growth without causing resistance.

Sven-Ulrik Gorr, Hunter V Brigman, Jadyn C Anderson

|May 12, 2020
The parotid secretory protein BPIFA2 is a salivary surfactant that affects lipopolysaccharide action.

Seshagiri Rao Nandula, Ian Huxford, Thomas T Wheeler

Pageof 2

Frequent Collaborators

1 joint publications

Jeffrey W Hall

1 joint publications

Juan E Abrahante